Company Announcements Office Australian Securities Exchange
Results from 2016 Annual General Meeting
In accordance with Listing Rule 3.13.2 and section 251AA of the Corporations Act, Nanosonics Limited advises details of the resolutions and the proxies received in respect of each resolution are set out in the attached proxy summary.
McGregor Grant
CFO and Company Secretary
Nanosonics Limited ABN 11 095 076 896 14 Mars Road, Lane Cove NSW 2066 Australia
Nanosonics Limited Annual General Meeting Friday, 04 November 2016 Voting Results
The following information is provided in accordance with section 251AA(2) of the Corporations Act 2001 (Cth).
Resolution details
Instructions given to validly appointed proxies
(as at proxy close)
Resolution
Result
Resolution
Resolution
Type
For
Against
Proxy's
Discretion
Abstain
Carried /
Not Carried
1 Election of a Director - Mr Maurie Stang
Ordinary
159,553,698
94.68%
8,487,424
5.04%
481,043
0.28%
69,624
Carried
2 Election of a Director - Mr Steven Sargent
Ordinary
167,987,837
99.69%
27,430
0.02%
480,643
0.29%
95,879
Carried
3 Election of a Director - Ms Marie McDonald
Ordinary
167,431,184
99.37%
575,097
0.34%
501,054
0.29%
84,454
Carried
4 Remuneration Report
Ordinary
143,057,463
99.14%
736,105
0.51%
507,468
0.35%
99,211
Carried
5 Issue of 42,138 Performance Rights and 211,306 Options to Chief Exective Officer and President, Mr Michael Kavanagh,under the 2016 Long-Term Incentive Scheme Invitation (2016 LTIS)
Ordinary
142,653,485
98.88%
886,506
0.61%
728,116
0.51%
132,140
Carried
6 Issue of 13,445 Performance Rights and 67,419 Options to the President Technology Development / Commercialisation, Dr Ronald Weinberger, under the 2016 Long-Term Incentive Scheme Invitation (2016 LTIS)
Ordinary
134,394,100
93.16%
9,385,789
6.51%
475,043
0.33%
145,315
Carried
7 Increase the Non-Executive Directors Remuneration
Ordinary
142,132,246
98.55%
1,601,143
1.11%
485,043
0.34%
181,815
Carried
8 Adoption of the Nanosonics Omnibus Equity Plan
Ordinary
133,927,025
99.06%
783,874
0.58%
486,256
0.36%
9,203,092
Carried
* Votes cast by a person who abstains on an item are not counted in calculating the required majority on a poll.
Nanosonics Limited published this content on 04 November 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 04 November 2016 08:30:03 UTC.
Public permalinkhttp://www.publicnow.com/view/2C8E8B7BCD74228DBD89195F347CDD4D0712C225
Nanosonics Limited is an Australia-based infection prevention company. The Company's principal activities include the manufacturing and distribution of the trophon ultrasound probe disinfector and its associated consumables and accessories. It is focused on the research, development, and commercialization of infection control and decontamination products and related technologies. Trophon technology includes high-frequency ultrasonic vibrations that generate a sonically activated hydrogen peroxide (H2O2) mist that kills bacteria, fungi, and viruses. Its products include trophon2, Nanosonics Auditpro, and trophon EPR. The Company's trophon2 includes AcuTrace radio frequency identification (RFID) technology, which enables digital record keeping and captures disinfection data. Nanosonics AuditPro is an automated digital system that combines clinician infection prevention decision making, with the Trophon 2 device infection control workflow data, and patient procedure information.